Clinical Trial Update: Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating camrelizumab in combination with cetuximab and chemotherapy for relapsed/metastatic squamous cell carcinoma of the head and neck has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of Head and Neck

Drugs mentioned

• Camrelizumab (camrelizumab)
• Cetuximab (cetuximab)

Snippet

Sponsor: Fudan University | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 2 | Status: COMPLETED